All lobbying filings

AEGIS LLC

Lobbying for TRIS PHARMA, INC. · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income · posted Apr 7, 2026

Official filing document

Bills named in this filing 2

HR 1227
Alternatives to PAIN Act
S 475
Alternatives to PAIN Act

Lobbying activity 1

Pharmacy

ADHD treatment. Implementation of the Infrastructure Investment and Jobs Act (or bipartisan infrastructure law). Traffic safety (distracted and impaired driving). Issues related to FDA approval. Patient access to non-opioid pain medicines. NO PAIN Act implementation. H.R.1227 / S.475: Alternatives to PAIN Act. Most-Favored Nation (MFN) International reference pricing. Make America Healthy Again (MAHA) Commission.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.